| Ria Dancel, MD | |
|
101 Manning Dr, Cb 7085, Chapel Hill, NC 27514-4220 | |
| (984) 974-1931 | |
| Not Available |
| Full Name | Ria Dancel |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023238037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 134666 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.
Systematic reviews and meta-analyses of the results of several studies are a common method for pooling data to gain further insight through access to larger numbers of patients.
Scientists at The University of Texas Health Science Center San Antonio are on to something that should bring joy to sunbathers everywhere. Studies show that certain plant substances, administered in combinations, have the ability to suppress skin cancer development in susceptible mice.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
› Verified 3 days ago
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.
Systematic reviews and meta-analyses of the results of several studies are a common method for pooling data to gain further insight through access to larger numbers of patients.
Scientists at The University of Texas Health Science Center San Antonio are on to something that should bring joy to sunbathers everywhere. Studies show that certain plant substances, administered in combinations, have the ability to suppress skin cancer development in susceptible mice.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
› Verified 3 days ago
| Entity Name | Chatham Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689967457 PECOS PAC ID: 4284807868 Enrollment ID: O20111026000545 |
News Archive
CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.
Systematic reviews and meta-analyses of the results of several studies are a common method for pooling data to gain further insight through access to larger numbers of patients.
Scientists at The University of Texas Health Science Center San Antonio are on to something that should bring joy to sunbathers everywhere. Studies show that certain plant substances, administered in combinations, have the ability to suppress skin cancer development in susceptible mice.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ria Dancel, MD 101 Manning Dr, Cb 7085, Chapel Hill, NC 27599-7085 Ph: (984) 974-1931 | Ria Dancel, MD 101 Manning Dr, Cb 7085, Chapel Hill, NC 27514-4220 Ph: (984) 974-1931 |
News Archive
CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.
Systematic reviews and meta-analyses of the results of several studies are a common method for pooling data to gain further insight through access to larger numbers of patients.
Scientists at The University of Texas Health Science Center San Antonio are on to something that should bring joy to sunbathers everywhere. Studies show that certain plant substances, administered in combinations, have the ability to suppress skin cancer development in susceptible mice.
A team of worldwide researchers including engineers from the University of Utah have received a $9.7-million grant to design and develop a new implantable device and surgical procedure for the deaf that hopefully will cut through the noise and produce much more detailed sound than traditional hearing-loss treatments.
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development.
› Verified 3 days ago
Dr. William Allen Kwan Jr., M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Drive Cb 7085, Chapel Hill, NC 27599 Phone: 984-974-1931 Fax: 984-974-2216 | |
Dr. Robert William Lampman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1931 Fax: 984-974-2216 | |
Dr. Amir Homayoun Barzin, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 590 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-0210 | |
Paul Douglas Ossman, M.D., M.P.H. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Unc Hospitals Chapel Hill Campus 101 Manning Dr, Campus Box 7085, Chapel Hill, NC 27599 Phone: 984-974-1931 Fax: 984-974-2216 | |
Shannon R Morris, M.D., PH.D Hospitalist Medicare: Not Enrolled in Medicare Practice Location: Physicians Office Building 3rd Floor Cb 7305, 170 Manning Drive, Chapel Hill, NC 27599 Phone: 919-483-7282 | |
Dr. Leonardo Marucci, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Campus Box 7085, Chapel Hill, NC 27599 Phone: 984-974-1931 Fax: 984-974-2216 |